LINC00857 and pancreatic adenocarcinoma: With the increase of LINC00857 expression, the total survival time of PAAD patients decreased significantly (Fig 1C, P = 0.0053), which further confirmed the importance of LINC00857 in the prognosis of PDAA patients.